None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with vaginitis aged 19 years or older 2. Those who meet at least one of the following criteria - Positive Ureaplasma in STD PCR test - Positive Mycoplasma in STD PCR test 3. Those who voluntarily decide to participate in this clinical study and are willing to comply with the clinical research protocol
Exclusion criteria
Exclusion criteria: 1. Those who have a history of adverse reactions to standard treatment drugs 2. Those who are pregnant 3. Those with intellectual or mental problems that make it difficult to decide on their own whether or not to participate in the study 4. Those without sexual experience 5. Those who have taken antibiotics or antifungal medications within a week 6. Other cases where participation in this clinical study is deemed unsuitable at the discretion of the researcher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of participants with reduced level of vaginitis-causing pathogens (Ureaplasma spp., Mycoplasma spp.) as a result of culture test in each group | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of participants with reduced detection of STI pathogens as a result of PCR testing in each group;Percentage of participants with improved vaginal pH in each group;Rate of change in symptom questionnaire scores (individual items and 10 cm VAS) in each group;Participant satisfaction in each group;Overall symptom improvement (evaluated by participants) in each group;Culture test results in study group;Vaginal pH in study group;Symptom questionnaire scores in study group;Adverse events / Serious adverse events | — |
Countries
Korea, Republic of
Contacts
Kim’s OB&GY Clinic